NCT03309384 Intraoperative Monitoring to Predict Postoperative Complications After Thyroidectomy
| NCT ID | NCT03309384 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Central Hospital, Nancy, France |
| Condition | Endocrine Procedural Complications |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2016-03-20 |
| Primary Completion | 2026-03-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2016-03-20 with a primary completion date of 2026-03-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to evaluate the role of intraoperative continous and intermittent neuromonitoring and intraoperative parathormone (PTH) to predict postoperative nerve morbidity and hypocalcemia.
Eligibility Criteria
Inclusion Criteria: * patients scheduled for total thyroidectomy in university of Nancy (University Hospital) Exclusion Criteria: * refusal to participate
Contact & Investigator
Brunaud
✉ l.brunaud@chru-nancy.frBrunaud
PRINCIPAL INVESTIGATOR
Central Hospital, Nancy, France
Frequently Asked Questions
Who can join the NCT03309384 clinical trial?
This trial is open to participants of all sexes, studying Endocrine Procedural Complications. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03309384 currently recruiting?
Yes, NCT03309384 is actively recruiting participants. Contact the research team at l.brunaud@chru-nancy.fr for enrollment information.
Where is the NCT03309384 trial being conducted?
This trial is being conducted at Vandœuvre-lès-Nancy, France.
Who is sponsoring the NCT03309384 clinical trial?
NCT03309384 is sponsored by Central Hospital, Nancy, France. The principal investigator is Brunaud at Central Hospital, Nancy, France. The trial plans to enroll 1,000 participants.